Startende i uge 16 blev placebobehandlede patienter skiftet til infliximab, og alle patienter fik herefter 5 mg/ kg infliximab hver 8. uge frem til uge 46.
Starting at week 16, placebo patients were switched to infliximab and all patients subsequently received 5 mg/ kg infliximab every 8 weeks up to week 46.